The Pink Fund provides up to $3,000 in grants to pay non-medical bills of men and women currently in treatment for breast cancer. More at thepinkfund.org. The Pan Foundation provides grants to women on Medicare with metastatic breast cancer who are currently in treatment. panfoundation.org. They have a new app called Fund Finder that helps patients find possible financial sources of help.
Here are some of our favorite interviews:
- Anne Doyle, Powering Up podcast series.
- Michigan Radio: : http://michiganradio.org/post/know-your-options-new-book-demystifies-breast-reconstruction
As we reported in our book, the nipple can be a real challenge for plastic surgeons. Unless women undergo nipple-sparing mastectomy, the nipple typically is made in a separate surgical procedure and inks used in medical offices have not been lasting. Here’s a new product for plastic surgery offices: Nipple-By-Number.
Major cancer news today in this important study identifying hundreds of genetic mutations that cause cancer, but at different rates of risk.
In the decade ahead, cancer researchers will continue to shed light on hundreds of genetic mutations _ gene variants as they are called _ that cause cancer at different rates of risk. This has major implications for people considering preventive surgeries for BRCA mutations, as well as others in families with too much cancer. If your family has breast, prostate, colon, pancreatic, colon or other cancer clusters, these findings have important implications for you.
Bottom line: If you are diagnosed, get a genetic analysis and talk with a medical oncology doctor, particularly for those in families with lots of cancer. This information should help tell you how much at risk you are; whether you need preventive surgeries; how often and earlier you should be tested to find cancer; what treatments are best for you; and what treatments you don’t need. This is one of the most important developments in cancer today. More to come.
More women are suing insurers for failure to pay for breast reconstruction, Bloomberg News reports.
Following testimony by women last spring about problems caused by breast implants, the FDA will require new warning labels on the devices, and defines risks and problems with them. The public has 60 days to comment on the new regulations. Here’s how to comment and the FDA notice issued today:
The draft guidance, Breast Implants – Certain Labeling Recommendations to Improve Patient Communication, provides recommendations for the form and content for certain labeling information for saline and silicone gel-filled breast implants, including:
- Boxed warning
- Patient decision checklist
- Materials/device descriptions, including types and quantities of chemicals and heavy metals found in or released by breast implants
- Silicone gel-filled breast implant rupture screening recommendations
- Patient device card
When final, the recommendations in this guidance will supplement or, in some cases, replace recommendations in the FDA’s Saline, Silicone Gel, and Alternative Breast Implants guidance, issued November 17, 2006.
This draft guidance will be open for public comments for 60 days, through December 23, 2019, at www.regulations.gov under docket number FDA-2019-D-4467.